FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378627997> ?p ?o ?g. }

• W4378627997 abstract "Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB has also been speculated to modify the tumor microenvironment including the immune response to tumors, the precise mechanism remains unclear. In our study, ERB suppressed the tumor growth of MC38 colon cancer in wildtype mice, whereas ERB failed to inhibit the tumor growth in Rag1-deficient mice which lack both B and T cells. Moreover, depletion of either CD4+ or CD8+ T cells abrogated the antitumor effect of ERB, indicating that both CD4+ and CD8+ T cells play an important role in ERB-induced antitumor effects. Furthermore, ERB treatment increased the number of tumor infiltrating lymphocytes (TILs) as well as the expression of activation markers (CD38 and CD69), immune checkpoint molecules (LAG3, TIGIT and Tim3) and cytotoxic molecules (granzyme B and perforin) in TILs. ERB upregulated E-cadherin expression in MC38. CD103 is a ligand of E-cadherin and induces T-cell activation. ERB increased the proportion of CD103+ cells in both CD4+ and CD8+ TILs. The ERB-induced antitumor effect with the increased TIL number and the increased expression of activation markers, inhibitory checkpoint molecules and cytotoxic molecules in TILs was abrogated in CD103-deficient mice. Collectively, these results suggest that ERB exerts antitumor effects by upregulation of E-cadherin expression in tumor cells and subsequent activation of CD103+ TILs." @default.
• W4378627997 created "2023-05-29" @default.
• W4378627997 creator A5004908859 @default.
• W4378627997 creator A5007192124 @default.
• W4378627997 creator A5013498188 @default.
• W4378627997 creator A5019908789 @default.
• W4378627997 creator A5024945765 @default.
• W4378627997 creator A5029718664 @default.
• W4378627997 creator A5032244860 @default.
• W4378627997 creator A5040512657 @default.
• W4378627997 creator A5040895870 @default.
• W4378627997 creator A5050520664 @default.
• W4378627997 creator A5057689148 @default.
• W4378627997 creator A5072079445 @default.
• W4378627997 date "2023-05-27" @default.
• W4378627997 modified "2023-10-01" @default.
• W4378627997 title "Eribulin mesylate exerts antitumor effects via CD103" @default.
• W4378627997 cites W1858568413 @default.
• W4378627997 cites W1895620535 @default.
• W4378627997 cites W2127152525 @default.
• W4378627997 cites W2131014265 @default.
• W4378627997 cites W2138941973 @default.
• W4378627997 cites W2156375860 @default.
• W4378627997 cites W2168663010 @default.
• W4378627997 cites W2259955047 @default.
• W4378627997 cites W2345876088 @default.
• W4378627997 cites W2586608125 @default.
• W4378627997 cites W2753016107 @default.
• W4378627997 cites W2760547921 @default.
• W4378627997 cites W2776348981 @default.
• W4378627997 cites W2781626404 @default.
• W4378627997 cites W2799941962 @default.
• W4378627997 cites W2888460025 @default.
• W4378627997 cites W2896899817 @default.
• W4378627997 cites W2918450407 @default.
• W4378627997 cites W2963088771 @default.
• W4378627997 cites W2991147947 @default.
• W4378627997 cites W2996606144 @default.
• W4378627997 cites W3011482860 @default.
• W4378627997 cites W3013837660 @default.
• W4378627997 cites W3082370759 @default.
• W4378627997 cites W3108774824 @default.
• W4378627997 cites W3121415532 @default.
• W4378627997 cites W3191624181 @default.
• W4378627997 doi "https://doi.org/10.1080/2162402x.2023.2218782" @default.
• W4378627997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37261089" @default.
• W4378627997 hasPublicationYear "2023" @default.
• W4378627997 type Work @default.
• W4378627997 citedByCount "0" @default.
• W4378627997 crossrefType "journal-article" @default.
• W4378627997 hasAuthorship W4378627997A5004908859 @default.
• W4378627997 hasAuthorship W4378627997A5007192124 @default.
• W4378627997 hasAuthorship W4378627997A5013498188 @default.
• W4378627997 hasAuthorship W4378627997A5019908789 @default.
• W4378627997 hasAuthorship W4378627997A5024945765 @default.
• W4378627997 hasAuthorship W4378627997A5029718664 @default.
• W4378627997 hasAuthorship W4378627997A5032244860 @default.
• W4378627997 hasAuthorship W4378627997A5040512657 @default.
• W4378627997 hasAuthorship W4378627997A5040895870 @default.
• W4378627997 hasAuthorship W4378627997A5050520664 @default.
• W4378627997 hasAuthorship W4378627997A5057689148 @default.
• W4378627997 hasAuthorship W4378627997A5072079445 @default.
• W4378627997 hasBestOaLocation W43786279971 @default.
• W4378627997 hasConcept C104317684 @default.
• W4378627997 hasConcept C127561419 @default.
• W4378627997 hasConcept C154317977 @default.
• W4378627997 hasConcept C167672396 @default.
• W4378627997 hasConcept C185592680 @default.
• W4378627997 hasConcept C202751555 @default.
• W4378627997 hasConcept C203014093 @default.
• W4378627997 hasConcept C2776090121 @default.
• W4378627997 hasConcept C2776107976 @default.
• W4378627997 hasConcept C2779118045 @default.
• W4378627997 hasConcept C2780380082 @default.
• W4378627997 hasConcept C3020616263 @default.
• W4378627997 hasConcept C502942594 @default.
• W4378627997 hasConcept C55493867 @default.
• W4378627997 hasConcept C86803240 @default.
• W4378627997 hasConcept C8891405 @default.
• W4378627997 hasConceptScore W4378627997C104317684 @default.
• W4378627997 hasConceptScore W4378627997C127561419 @default.
• W4378627997 hasConceptScore W4378627997C154317977 @default.
• W4378627997 hasConceptScore W4378627997C167672396 @default.
• W4378627997 hasConceptScore W4378627997C185592680 @default.
• W4378627997 hasConceptScore W4378627997C202751555 @default.
• W4378627997 hasConceptScore W4378627997C203014093 @default.
• W4378627997 hasConceptScore W4378627997C2776090121 @default.
• W4378627997 hasConceptScore W4378627997C2776107976 @default.
• W4378627997 hasConceptScore W4378627997C2779118045 @default.
• W4378627997 hasConceptScore W4378627997C2780380082 @default.
• W4378627997 hasConceptScore W4378627997C3020616263 @default.
• W4378627997 hasConceptScore W4378627997C502942594 @default.
• W4378627997 hasConceptScore W4378627997C55493867 @default.
• W4378627997 hasConceptScore W4378627997C86803240 @default.
• W4378627997 hasConceptScore W4378627997C8891405 @default.
• W4378627997 hasFunder F4320332097 @default.
• W4378627997 hasIssue "1" @default.
• W4378627997 hasLocation W43786279971 @default.
• W4378627997 hasLocation W43786279972 @default.
• W4378627997 hasLocation W43786279973 @default.

• next